Sabra Healthcare REIT, Inc.
SBRA Real Estate Reit Healthcare Facilities
Sabra Healthcare REIT, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $774.6 million, up 10.2% from fiscal 2024.
- Revenue
- +31.3%
- EPS
- +24.1%
- Free cash flow
- +26.7%
- Total debt
- −5.99%
Quarter to September 2026, against a year earlier
Follow SBRA
Alert me
Sabra Healthcare REIT, Inc. (SBRA) EV/EBITDA
As of 6 November 2026, Sabra Healthcare REIT, Inc. (SBRA) trades at a EV/EBITDA of 20.0×. Over the past ten years it has ranged from 8.5× (April 2020) to 24.9× (October 2017); the current reading is higher than 96% of that period. That is above the Reit Healthcare Facilities industry median of 17.6× and above the Real Estate sector median of 15.3×.
EV/EBITDA, daily
Embed this chart
Annual newest first
| Period | EV/EBITDA | Change |
|---|---|---|
| FY2025 | 15.8× | 1.03% |
| FY2024 | 15.7× | 8.26% |
| FY2023 | 14.5× | (11.40%) |
| FY2022 | 16.3× | 18.43% |
| FY2021 | 13.8× | 0.34% |
| FY2020 | 13.7× | (13.52%) |
| FY2019 | 15.9× | 29.09% |
| FY2018 | 12.3× | (21.03%) |
| FY2017 | 15.6× | 12.38% |
| FY2016 | 13.9× | 6.03% |
Quarterly newest first
| Period | EV/EBITDA | Change |
|---|---|---|
| Sep 2026 | 19.1× | (4.36%) |
| Jun 2026 | 20.0× | 22.50% |
| Mar 2026 | 16.3× | 2.94% |
| Dec 2025 | 15.8× | 1.10% |
| 43 more quarters | Free account |
Against its own ten years
EV/EBITDA against peers
| Company | EV/EBITDA |
|---|---|
| LTC LTC Properties, Inc. compare | 5.7× |
| HR Healthcare Realty Trust Incorporated compare | 9.8× |
| DOC Healthpeak Properties, Inc. compare | 15.2× |
| NHI National Health Investors, Inc. compare | 15.9× |
| OHI Omega Healthcare Investors, Inc. compare | 17.6× |
| DHC Diversified Healthcare Trust compare | 18.8× |
| SBRA Sabra Healthcare REIT, Inc. | 20.0× |
| CTRE CareTrust REIT, Inc. compare | 21.5× |
| AHR American Healthcare REIT, Inc. compare | 31.2× |
| Reit Healthcare Facilities industry median | 17.6× |
| Real Estate sector median | 15.3× |
| Market median | 10.9× |
What EV/EBITDA is
Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)
More on SBRA
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- The full statement